EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel blaCTX-M-261 variant and a blaNDM-5

Jie Wei, Shimei Shen, Qinghuan Zhang, Jinping Lu, Shenglan Mao, Chunhong Zou, Hua Zhou, YeLin Wei, Xingyi Ou, Jinyu Huang, Deqiang Wang, Xiaobin Li und 3 weitere

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04765-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Jie Wei und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), Zhuhai, China. Hauptthemen laut MEDLINE: Ceftazidime, beta-Lactamases, Azabicyclo Compounds, Drug Combinations. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GuangDong Basic and Applied Basic Research Foundation, Xiangshan Talent Project of Zhuhai People's Hospital, Clinical Research Promotion Project of Zhuhai People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The detection rate of Salmonella enterica serovar 1,4,[5], 12: i: - (S. 1,4,[5], 12: i: -) has increased as the most common serotype globally. A S . 1,4,[5], 12: i: - strain named ST3606 (sequence type 34), isolated from a fecal specimen of a child with acute diarrhea hospitalized in a tertiary hospital in China, was firstly reported to be resistant to carbapenem and ceftazidime-avibactam. The aim of this study was to characterize the whole-genome sequence of S. 1,4,[5], 12: i: - isolate, ST3606, and explore its antibiotic resistance genes and their genetic environments.

Methods

The genomic DNA of S. 1,4,[5], 12: i: - ST3606 was extracted and performed with single-molecule real-time sequencing. Resistance genes, plasmid replicon type, mobile elements, and multilocus sequence types (STs) of ST3606 were identified by ResFinder 3.2, PlasmidFinder, OriTfinder database, ISfinder database, and MLST 2.0, respectively. The conjugation experiment was utilized to evaluate the conjugation frequency of pST3606-2. Protein expression and enzyme kinetics experiments of CTX-M were performed to analyze hydrolytic activity of a novel CTX-M-261 enzyme toward several antibiotics.

Results

Single-molecule real-time sequencing revealed the coexistence of a 109-kb IncI1-Iα plasmid pST3606-1 and a 70.5-kb IncFII plasmid pST3606-2. The isolate carried resistance genes, including bla NDM-5 , sul1 , qacE , aadA2 , and dfrA12 in pST3606-1, bla TEM-1B , aac (3)- lld , and bla CTX-M-261 , a novel bla CTX-M-1 family member, in pST3606-2, and aac (6')- Iaa in chromosome. The bla CTX-M-261 was derived from bla CTX-M-55 by a single-nucleotide mutation 751G>A leading to amino acid substitution of Val for Met at position 251 (Val251Met), which conferred CTX-M increasing resistance to ceftazidime verified by antibiotics susceptibility testing of transconjugants carrying pST3606-2 and steady-state kinetic parameters of CTX-M-261. pST3606-1 is an IncI1-α incompatibility type that shares homology with plasmids of pC-F-164_A-OXA140, pE-T654-NDM-5, p_dm760b_NDM-5, and p_dmcr749c_NDM-5. The conjugation experiment demonstrated that pST3606-2 was successfully transferred to the Escherichia coli recipient C600 with four modules of OriTfinder.

Conclusion

Plasmid-mediated horizontal transfer plays an important role in bla NDM-5 and bla CTX-M-261 dissemination, which increases the threat to public health due to the resistance to most β-lactam antibiotics. This is the first report of bla CTX-M-261 and bla NDM-5 in S. 1,4,[5], 12: i: -. The work provides insights into the enzymatic function and demonstrates the ongoing evolution of CTX-M enzymes and confirms urgency to control resistance of S . 1,4,[5], 12: i: -.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ceftazidimebeta-LactamasesAzabicyclo CompoundsDrug CombinationsAnti-Bacterial AgentsSalmonella entericaMicrobial Sensitivity TestsSalmonella InfectionsHumansChinaWhole Genome SequencingDrug Resistance, Multiple, BacterialSerogroupPlasmidsFecesGenome, Bacterial

Stichwörter der Autor:innen

Bla CTX-M-261Bla NDM-5Salmonella enterica serovar 1,4,[5]12: i: -Ceftazidime-avibactamIncI1-I(α)

Substanzen

Ceftazidimebeta-LactamasesAzabicyclo CompoundsDrug CombinationsAnti-Bacterial Agentsavibactam, ceftazidime drug combination

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), Zhuhai, China.
  • Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongq…
  • Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing, China.
  • The First People's Hospital of Xiaoshan Hangzhou, Hangzhou, China.
  • Zhuhai Precision Medical Center, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China.
  • Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China. wanq23@mail.sysu.edu.cn.

Förderung

  • GuangDong Basic and Applied Basic Research Foundation
  • Xiangshan Talent Project of Zhuhai People's Hospital
  • Clinical Research Promotion Project of Zhuhai People's Hospital
  • Cultivation Project of Zhuhai People's Hospital
  • Guangzhou science and technology plan project
  • Xiangshan Talent Project of Zhuhai People’s Hospital
  • Cultivation Project of Zhuhai People’s Hospital

Zitieren

APA

Wei, J., Shen, S., Zhang, Q., Lu, J., Mao, S., Zou, C., Zhou, H., Wei, Y., Ou, X., Huang, J., Wang, D., Li, X., Wan, Q., Shan, B., & Zhang, Z. (2024). Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel blaCTX-M-261 variant and a blaNDM-5. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04765-3

Vancouver

Wei J, Shen S, Zhang Q, Lu J, Mao S, Zou C, et al. Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel blaCTX-M-261 variant and a blaNDM-5. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04765-3

BibTeX
@article{Wei2024,
  author = {Wei, Jie and Shen, Shimei and Zhang, Qinghuan and Lu, Jinping and Mao, Shenglan and Zou, Chunhong and Zhou, Hua and Wei, YeLin and Ou, Xingyi and Huang, Jinyu and Wang, Deqiang and Li, Xiaobin and Wan, Qun and Shan, Baoju and Zhang, Zhenlin},
  title = {Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel blaCTX-M-261 variant and a blaNDM-5},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04765-3}
}
Kostenlos starten →